Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial

IMPORTANCE: Propranolol for infantile hemangiomas (IH) has been shown to be effective and relatively safe. However, other less lipophilic β-blockers, such as nadolol, may be preferable in individuals who experience propranolol unresponsiveness or adverse events. OBJECTIVE: To document the noninferio...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Elena, Lara-Corrales, Irene, Sibbald, Cathryn, Liy-Wong, Carmen, Kanigsberg, Nordau, Drolet, Beth, Ma, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576629/
https://www.ncbi.nlm.nih.gov/pubmed/34747977
http://dx.doi.org/10.1001/jamapediatrics.2021.4565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576629/
https://www.ncbi.nlm.nih.gov/pubmed/34747977
http://dx.doi.org/10.1001/jamapediatrics.2021.4565

Ejemplares similares